Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 1 1

Status

Terminated 6Completed 5Withdrawn 1

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Conditions

Leiomyoma 6Menorrhagia 3

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Interventional × vilaprisan × Clear all
NCT03194646 2025-07-28

ASTEROID 6

Bayer

Phase 3 Terminated
1,272 enrolled 16 charts

Leiomyoma

NCT03240523 2024-10-18

ASTEROID 5

Bayer

Phase 3 Terminated
766 enrolled

Leiomyoma

NCT03400943 2023-05-03

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Bayer

Phase 3 Terminated
93 enrolled 19 charts

Leiomyoma, Menorrhagia

NCT03476928 2022-07-08

ASTEROID 8

Bayer

Phase 3 Terminated
153 enrolled

Leiomyoma, Menorrhagia

NCT03400956 2022-06-30

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Bayer

Phase 3 Terminated
103 enrolled 18 charts

Leiomyoma, Menorrhagia

NCT03342859 2021-01-06

Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned

Bayer

Phase 1 Terminated
10 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡